EOLO PHARMA Drug discovery company pursuing targeted compounds for metabolic diseases Opportunity Obesity and its associated pathologies, mainly type II diabetes (DT2) and cardiovascular diseases (CVD) are considered one of the greatest health challenges of the 21st...
Recent Comments